Sentence examples for and efficient pathway for from inspiring English sources

Moreover, 1D nanostructure can provide a direct and efficient pathway for electrons from sensitizer to conductive substrate compared to the disordered electron pathway in nanoparticles [23 26].

The in vivo sensitivity of bone cells to even extremely small accelerations reported here suggests an alternative and efficient pathway for the transduction of physical signals to the transcriptional machinery of the nucleus (Fig. 4).

As a large team cares for patients, clear and efficient pathways for communication and workflows are necessary to ensure the patient experience is as seamless and organized as possible.

Further work needs to be done to determine whether the observed differences in centres' performance are due to variations in availability of resources or because certain centres have more organised and efficient pathways for patients.

It also means a step change is needed in providing more effective and efficient pathways of care, particularly for people with chronic disease, to avoid the need for costly hospital treatment.

Simultaneously, this novel and efficient pathway could open new opportunities for further investigating about the properties of molybdate materials.

Pathview can be easily combined with other tools for automated and efficient pathway analysis pipelines.

The Rad51p-dependent pathway of recombination, also requiring Rad52p, Rad55p, Rad57p and Rad54p, is the most efficient pathway for gene conversion and is also required for repair of most double-strand DNA breaks in mitotic cells (Johnson and Symington 1995).

For instance, production of seedlings in low cost localities for outplanting in different and distant environments provides only a marginal net economic benefit to the whole area, but provides an efficient pathway for pathogen and pest dispersal.

K2CO3 is assumed to provide an efficient pathway for CO2 and water to travel into the core region of the sorbent via a reversible reaction between K2CO3 and KHCO3.

In summary, a CP strategy that incorporates well-defined agents, clinical and validated SE, and high-risk cohorts defined by genetic and acquired risk factors in a series of well-designed randomized controlled trials provides an efficient pathway for evaluating and approving new agents for PCa prevention.